Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA1JN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,284
Award facts
- Contract value 100% obligated
- $12,284.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 23, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $12,284.44 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes. This firm fixed-price contract is scheduled for completion by January 26, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a fully competitive basis without set-aside restrictions. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The delivery order for Dupixent represents a routine procurement task executed under this master contract framework to fulfill ongoing government healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FA1JN?
SPE2DR26FA1JN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FA1JN worth?
The government has obligated $12,284 on SPE2DR26FA1JN.
Is contract SPE2DR26FA1JN an order under another contract?
Yes. SPE2DR26FA1JN is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA1JN competed?
The extent of competition for SPE2DR26FA1JN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award